HUPO World Congress (Human Proteome Organization)
Connect with Seer at HUPO World Congress in Toronto
Booth #801
November 9 – 13, 2025
Toronto, ON
Join us at HUPO World Congress to learn how Seer can help reveal more of the proteome for you, so you can unveil new discoveries for the world.
Attend our Breakfast Symposium
Seer’s 2025 HUPO Breakfast Symposium will highlight the use of deep plasma and tissue proteomics to illuminate disease mechanisms and reveal clinically relevant biomarkers in cardiovascular and aging biology. Dr. Uros Kuzmanov will present findings from a proteomic study of paired myocardial and serum samples from patients with end-stage heart disease that identified candidate biomarkers of right ventricular failure. Dr. Nathan Basisty will share how deep proteomic analysis of mouse serum uncovered paracrine mediators of physical dysfunction caused by senescent cells. Together, these talks showcase the power of Seer’s Proteograph® platform to uncover novel biomarkers, link circulating proteins to disease mechanisms, and accelerate translational insights for cardiovascular failure and aging-related decline.
- Date: November 10, 2025
- Time: 8:00 – 9:00am ET
- Location: Room Pier 2+3
Featured Speakers
Nathan Basisty, PhD NIH Distinguished Scholar and InvestigatorNational Institute on Aging
Uros Kuzmanov, PhD Senior Research AssociateUniversity of Toronto and Ted Rogers Centre for Heart Research
Stay Connected
Join our LinkedIn community to stay up to date on the latest in unbiased proteomics.
Contact us to meet with an expert or request more information.
Keep Exploring
On-Demand Webinars
Explore our on-demand webinar gallery with groundbreaking biological studies leveraging Seer’s highly sensitive and unbiased proteomics technology.
Proteograph® Product Suite
Look for answers in every dimension with Seer’s Proteograph Product Suite to push your biological research forward.
Publications & Resource Library
Explore posters and publications demonstrating the integration of proteomics in biomarker discovery, cancer research, and computational and assay methods.